Magnetic resonance imaging of Alzheimer’s disease

[1]  Brigitte Landeau,et al.  Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study , 2005, NeuroImage.

[2]  Kiralee M. Hayashi,et al.  Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia , 2004, NeuroImage.

[3]  Paul M. Thompson,et al.  Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment , 2005, NeuroImage.

[4]  N. Schuff,et al.  Longitudinal volumetric MRI change and rate of cognitive decline , 2005, Neurology.

[5]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[6]  M N Rossor,et al.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.

[7]  Nobuhisa Iwata,et al.  19F and 1H MRI detection of amyloid β plaques in vivo , 2005, Nature Neuroscience.

[8]  Matthijs Oudkerk,et al.  Brain changes with aging: MR spectroscopy at supraventricular plane shows differences between women and men. , 2003, Radiology.

[9]  Nick C Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Frisoni,et al.  Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry , 2002, Journal of neurology, neurosurgery, and psychiatry.

[11]  S. Leurgans,et al.  MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD , 2004, Neurobiology of Aging.

[12]  Philip Scheltens,et al.  Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment , 2004, Neurology.

[13]  B Horwitz,et al.  Critical analysis of the use of computer‐assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type , 1990, Neurology.

[14]  Daniel H. Mathalon,et al.  Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus , 1995, Neurobiology of Aging.

[15]  O Nalcioglu,et al.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.

[16]  J. Coyle,et al.  Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.

[17]  E G Tangalos,et al.  1H MR spectroscopy in common dementias , 2004, Neurology.

[18]  S Lehéricy,et al.  Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[19]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[20]  R. Woods,et al.  Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.

[21]  C. Jack,et al.  Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. , 2003, AJNR. American journal of neuroradiology.

[22]  Nick C Fox,et al.  Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease , 1999, The Lancet.

[23]  Hidenao Fukuyama,et al.  Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[24]  J. O'Brien,et al.  A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[25]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[26]  H. Soininen,et al.  Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[27]  E. Sullivan,et al.  Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease , 2000, The Lancet.

[28]  P Julin,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[29]  Antonio F. Govoni,et al.  Quantitative nmr measurements of hippocampal atrophy in Alzheimer's disease :Seab JP, Jagust WJ, Wong STS, Roos MS, Reed BR, Budinger TF (Donner Laboratory, Lawrence Berkeley Laboratory, University of California, Berkeley, CA 94720, USA). Magn Reson Med 1988;8:200–208 , 1989 .

[30]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[31]  M. Albert,et al.  Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.

[32]  A. Smith,et al.  The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[33]  S Minoshima,et al.  Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  T. Ogawa,et al.  Usefulness of diffusion tensor imaging of white matter in alzheimer disease and vascular dementia , 2004, Acta radiologica.

[35]  Walter Kukull,et al.  Progression to dementia in patients with isolated memory loss , 1997, The Lancet.

[36]  F Barkhof,et al.  The Diagnostic Value of Magnetic Resonance Imaging and Technetium 99m‐HMPAO Single‐Photon-Emission Computed Tomography for the Diagnosis of Alzheimer Disease in a Community‐Dwelling Elderly Population , 1997, Alzheimer disease and associated disorders.

[37]  S. Rose,et al.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[38]  Paul M. Thompson,et al.  Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects , 2004, NeuroImage.

[39]  K. Marder,et al.  Neuropsychological detection and characterization of preclinical Alzheimer's disease , 1995, Neurology.

[40]  M. Albert,et al.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.

[41]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[42]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[43]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[44]  J. Gawehn,et al.  PROTON MAGNETIC RESONANCE SPECTROSCOPY IN DEMENTIA OF ALZHEIMER TYPE , 1997, International journal of geriatric psychiatry.

[45]  C. Jack,et al.  Memory and MRI-based hippocampal volumes in aging and AD , 2000, Neurology.

[46]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[47]  G. Frisoni,et al.  Linear measures of atrophy in mild Alzheimer disease. , 1996, AJNR. American journal of neuroradiology.

[48]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[49]  C. Jack,et al.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.

[50]  Emma J. Burton,et al.  Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry , 2002, NeuroImage.

[51]  D. Bennett,et al.  White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study , 2006, Neurobiology of Aging.

[52]  H. Soininen,et al.  MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. , 1998, AJNR. American journal of neuroradiology.

[53]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[54]  Nick C. Fox,et al.  Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.

[55]  I G McKeith,et al.  MRI volumetric study of dementia with Lewy bodies , 2000, Neurology.

[56]  S. Leurgans,et al.  MRI predictors of risk of incident Alzheimer disease , 2005, Neurology.

[57]  F. Jessen,et al.  A Comparative Study of the Different N-Acetylaspartate Measures of the Medial Temporal Lobe in Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[58]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[59]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[60]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[61]  W. Jagust,et al.  Functional Imaging Patterns in Alzheimer's Disease Relationships to Neurobiology a , 1996, Annals of the New York Academy of Sciences.

[62]  P. Basser,et al.  In vivo fiber tractography using DT‐MRI data , 2000, Magnetic resonance in medicine.

[63]  C. Cuénod,et al.  Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. , 1993, Archives of neurology.

[64]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[65]  J. Detre,et al.  Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. , 1999, European journal of radiology.

[66]  C. Jack,et al.  Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans. , 2001, Archives of neurology.

[67]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[68]  H. Tohgi,et al.  MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report. , 1995, AJNR. American journal of neuroradiology.

[69]  M N Rossor,et al.  Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia , 2001, Neurology.

[70]  Nick C. Fox,et al.  An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease , 2004, NeuroImage.

[71]  Karl J. Friston,et al.  Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias , 2002, NeuroImage.

[72]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[73]  J. Baron,et al.  In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.

[74]  Andrea Federspiel,et al.  Examining the gateway to the limbic system with diffusion tensor imaging: The perforant pathway in dementia , 2006, NeuroImage.

[75]  D A Bennett,et al.  Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease , 2000, Hippocampus.

[76]  K. Jobst,et al.  Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias , 1997, International Psychogeriatrics.

[77]  J A Yesavage,et al.  Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease. , 1997, Archives of neurology.

[78]  K. Jellinger.  Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia , 2000, Journal of neurology, neurosurgery, and psychiatry.

[79]  Griselda J. Garrido,et al.  A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease , 2003, Neurobiology of Aging.

[80]  Michael Garwood,et al.  In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.

[81]  H. Soininen,et al.  Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age‐associated memory impairment , 1994, Neurology.

[82]  M. Sliwinski,et al.  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons , 1994, Neurology.

[83]  Atsuo Tanaka,et al.  High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease , 2003, NeuroImage.

[84]  J. Yesavage,et al.  Structural MRI correlates of recognition memory in Alzheimer's disease , 1998, Journal of the International Neuropsychological Society.

[85]  G. Frisoni,et al.  A voxel based morphometry study on mild cognitive impairment , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[86]  S S Furuie,et al.  Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer’s disease: a combined MRI and SPECT study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[87]  R. Edelman,et al.  Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[88]  R. Sperling,et al.  Noninvasive perfusion MRI in Alzheimer's disease , 1996, Neurology.

[89]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[90]  Harald Hampel,et al.  Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease , 2002, Journal of the Neurological Sciences.

[91]  平田 容子,et al.  Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2007 .

[92]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[93]  P. Antuono,et al.  Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with 1H-MRS at 0.5 T , 2001, Neurology.

[94]  P Sachdev,et al.  Magnetic resonance spectroscopy in AD , 2001, Neurology.

[95]  C. Poupon,et al.  Regularization of Diffusion-Based Direction Maps for the Tracking of Brain White Matter Fascicles , 2000, NeuroImage.

[96]  R Stewart,et al.  Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study , 2001, Neurology.

[97]  J. Detre,et al.  Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. , 1998, Radiology.

[98]  Frederik Barkhof,et al.  Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.

[99]  B D Ross,et al.  In vivo MR spectroscopy of human dementia. , 1998, Neuroimaging clinics of North America.

[100]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[101]  C. Jack,et al.  DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment , 2005, Neurology.

[102]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[103]  Emma J. Burton,et al.  A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.

[104]  Hirofumi Sakurai,et al.  Atrophy of the Substantia innominata on Magnetic Resonance Imaging Predicts Response to Donepezil Treatment in Alzheimer’s Disease Patients , 2003, Dementia and Geriatric Cognitive Disorders.

[105]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[106]  F Träber,et al.  Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD , 2000, Neurology.

[107]  E G Tangalos,et al.  Memory function in very early Alzheimer's disease , 1994, Neurology.

[108]  N. Schuff,et al.  Higher atrophy rate of entorhinal cortex than hippocampus in AD , 2004, Neurology.

[109]  J. Baron,et al.  Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[110]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.

[111]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[112]  Frederik Barkhof,et al.  Pathological Aging of the Brain: An Overview , 2004, Topics in magnetic resonance imaging : TMRI.

[113]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[114]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[115]  I. McKeith,et al.  Temporal lobe atrophy on MRI in Parkinson disease with dementia , 2005, Neurology.

[116]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[117]  M. Pugliese,et al.  Severe cognitive impairment correlates with higher cerebrospinal fluid levels of lactate and pyruvate in a canine model of senile dementia , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[118]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[119]  R. V. Van Heertum,et al.  SPECT perfusion imaging in the diagnosis of Alzheimer’s disease , 2001, Neurology.

[120]  Vascular factors and Alzheimer disease. , 1999, Alzheimer disease and associated disorders.

[121]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[122]  Susumu Mori,et al.  Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging , 2004, Magnetic resonance in medicine.

[123]  M N Rossor,et al.  Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.

[124]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[125]  Hiroaki Kazui,et al.  Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease , 2001, Neurology.

[126]  E. Bigler,et al.  Dementia, quantitative neuroimaging, and apolipoprotein E genotype. , 2000, AJNR. American journal of neuroradiology.

[127]  Peter Stoeter,et al.  Functional implications of hippocampal volume and diffusivity in mild cognitive impairment , 2005, NeuroImage.

[128]  J. Kaye,et al.  Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia , 1997, Neurology.

[129]  Gwenn S. Smith,et al.  EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.

[130]  S. Lehéricy,et al.  Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease , 1993, The Journal of comparative neurology.

[131]  Alberto Beltramello,et al.  A comparison between the accuracy of voxel‐based morphometry and hippocampal volumetry in Alzheimer's disease , 2004, Journal of magnetic resonance imaging : JMRI.

[132]  V. Hachinski,et al.  Cerebrovascular Pathology in Alzheimer's Disease: Cause, Effect or Epiphenomenon? , 1997, Annals of the New York Academy of Sciences.

[133]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[134]  D. Bennett,et al.  MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.

[135]  S. Resnick,et al.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.

[136]  Hilkka Soininen,et al.  Hippocampus in Alzheimer’s disease: a 3-year follow-up MRI study , 2000, Biological Psychiatry.

[137]  M. Higuchi,et al.  19 Fa nd 1 H MRI detection of amyloid b plaques in vivo , 2005 .

[138]  Paul M. Thompson,et al.  Mapping hippocampal and ventricular change in Alzheimer disease , 2004, NeuroImage.

[139]  A. Convit,et al.  Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.

[140]  Marc Dhenain,et al.  Senile plaques do not induce susceptibility effects in T 2*‐weighted MR microscopic images , 2002, NMR in biomedicine.

[141]  H. Soininen,et al.  Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease , 1996, Neurology.

[142]  E. Mori,et al.  Medial temporal and whole-brain atrophy in dementia with Lewy bodies , 1998, Neurology.

[143]  J. Gee,et al.  What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. , 2003, Brain : a journal of neurology.

[144]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[145]  J. Detre,et al.  Reduced Transit-Time Sensitivity in Noninvasive Magnetic Resonance Imaging of Human Cerebral Blood Flow , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[146]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[147]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[148]  B. L. Miller,et al.  Atrophy rates of entorhinal cortex in AD and normal aging , 2003, Neurology.

[149]  Takashi Inoue,et al.  Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging , 2002, Neuroscience Letters.

[150]  B D Ross,et al.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.

[151]  A Hofman,et al.  MR spectroscopy of brain white matter in the prediction of dementia , 2006, Neurology.

[152]  Thomas Wisniewski,et al.  Magnetic resonance imaging of amyloid plaques in transgenic mice. , 2005, Methods in molecular biology.

[153]  Matthias J. Müller,et al.  Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment , 2005, Neurobiology of Aging.

[154]  Clifford R Jack,et al.  In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice , 2005, The Journal of Neuroscience.

[155]  F Kruggel,et al.  Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly , 2001, Neurobiology of Aging.

[156]  G. Fein,et al.  Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.

[157]  A. Convit,et al.  Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[158]  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons , 1995 .

[159]  G A Johnson,et al.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[160]  E. Mori,et al.  Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. , 2001, Neurology.

[161]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[162]  B L Miller,et al.  Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease , 1997, Neurology.

[163]  D. Davies,et al.  MYOCARDIAL DISORDERS IN THE ELDERLY. , 1963, Lancet.

[164]  J. Wegiel,et al.  MRI of entorhinal cortex in mild Alzheimer's disease , 1999, The Lancet.

[165]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[166]  P. V. van Zijl,et al.  Three‐dimensional tracking of axonal projections in the brain by magnetic resonance imaging , 1999, Annals of neurology.

[167]  H. Hanyu,et al.  Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.

[168]  A. Hofman,et al.  MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people , 2004, European Radiology.

[169]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[170]  Thomas Wisniewski,et al.  Magnetic Resonance in Medicine 51:794–798 (2004) MRI Assessment of Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease , 2022 .

[171]  W. Jagust,et al.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.

[172]  P. Doraiswamy,et al.  In vivo amyloid imaging in Alzheimer’s disease , 2004, Neuroradiology.

[173]  服部 憲明.  Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease , 2002 .

[174]  E. Kaplan,et al.  The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. , 1995, Archives of neurology.

[175]  R. Floris,et al.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. , 2001, AJNR. American journal of neuroradiology.

[176]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[177]  I G McKeith,et al.  Medial temporal lobe atrophy on MRI in dementia with Lewy bodies , 1999, Neurology.

[178]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.